Trial Profile
A single-dose, randomized, 3-period crossover study evaluating pharmacokinetic effects on Delafloxacin when administered with or without high fat meal (food-effect study)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Nov 2015
Price :
$35
*
At a glance
- Drugs Delafloxacin (Primary)
- Indications Skin and soft tissue infections
- Focus Pharmacokinetics
- 27 Nov 2015 New trial record
- 12 Nov 2015 Results published in the Clinical Therapeutics